HA
The startup develops a bioactive peptide aimed at promoting mucosal healing and achieving clinical remission in patients. By focusing on enhancing adrenomedullin, the company addresses the unmet medical needs associated with mucosal damage and related conditions.
Updated 18 months ago
Funding
$11.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
JSFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a bioactive peptide aimed at promoting mucosal healing and achieving clinical remission in patients. By focusing on enhancing adrenomedullin, the company addresses the unmet medical needs associated with mucosal damage and related conditions.